This paper examines the use of photoacoustic spectroscopy (PAS) at an excitation wavelength of 905 nm for making continuous non-invasive blood glucose measurements. The theoretical background of the measurement technique is verified through simulation. An apparatus is fabricated for performing photoacoustic measurements in vitro on glucose solutions and in vivo on human subjects. The amplitude of the photoacoustic signals measured from glucose solutions is observed to increase with the solution concentration, while photoacoustic amplitude obtained from in vivo measurements follows the blood glucose concentration of the subjects, indicating a direct proportionality between the two quantities. A linear calibration method is applied separately on measurements obtained from each individual in order to estimate the blood glucose concentration. The estimated glucose values are compared to reference glucose concentrations measured using a standard glucose meter. A plot of 196 measurement pairs taken over 30 normal subjects on a Clarke error grid gives a point distribution of 82.65% and 17.35% over zones A and B of the grid with a mean absolute relative deviation (MARD) of 11.78% and a mean absolute difference (MAD) of 15.27 mg/dl (0.85 mmol/l). The results obtained are better than or comparable to those obtained using photoacoustic spectroscopy based methods or other non-invasive measurement techniques available. The accuracy levels obtained are also comparable to commercially available continuous glucose monitoring systems.
The use of near infra red (NIR) photoacoustic spectroscopy (PAS) for continuous non-invasive glucose measurement is outlined in the paper. A photoacoustic (PA) measurement apparatus was constructed and PA measurements were made on glucose solutions at multiple NIR excitation wavelengths. A variety of time and frequency domain features, including amplitude and area based features, were extracted from the PA measurements. These features were observed to be proportional to the glucose concentration of the sample. PA measurements from samples of whole blood at different glucose concentrations showed similar results. Subsequently, in vivo PA measurements made on a cohort of 30 volunteers were calibrated using a quadratic fit, and the results were compared to reference glucose concentrations made using a regular blood glucose meter. A comparison of 196 measurement pairs of predicted and reference glucose concentrations using a Clarke Error Grid gave a point distribution of 87.24% and 12.76% over zones A and B of the grid, with no measurement pairs falling in unacceptable zones C-E of the error grid. The predicted measurements had a mean absolute difference (MAD) of 12.57 ± 13.90 mg/dl and a mean absolute relative difference (MARD) of 9.61% ± 10.55%. This is an improvement over previous results obtained using PAS and other non-invasive techniques, validating the potential of PAS for continuous noninvasive glucose monitoring.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.